Does Depression Increase the Risk of Dementia?

Your mother has been dealing with depression for years. Now in her seventies, she’s showing signs of memory problems—forgetting conversations, repeating questions, struggling with names. Is this normal aging, or could her decades of depression have somehow set the stage for something more serious? It’s the kind of question that keeps you awake at night, scrolling through medical articles at 2 AM, trying to understand if there’s a connection between the mental health struggles you’ve watched her navigate and the cognitive changes you’re now witnessing.

The relationship between depression and dementia has puzzled researchers, clinicians, and families for decades. On the surface, they share some symptoms—difficulty concentrating, memory problems, slowed thinking—making it hard to distinguish where one ends and the other begins. But beneath these surface similarities lies a more complex and concerning question: does experiencing depression actually increase someone’s likelihood of developing dementia years or decades later? Or are the memory problems that appear alongside depression simply early warning signs that dementia was already beginning?

The answer emerging from research is both clear and complicated. Study after study confirms that people with a history of depression face elevated risk for developing dementia, particularly Alzheimer’s disease, later in life. Large population studies tracking thousands of individuals over decades consistently show this association. One major analysis found that depression nearly doubled the risk of developing dementia, even after accounting for age, genetics, and other health factors. Another study following older adults with depression and mild cognitive impairment found that a staggering proportion progressed to Alzheimer’s within just a few years, especially those with recently active depression.

But here’s where it gets tricky: the timing matters enormously. Recent depression—meaning active within the past two years—shows much stronger association with dementia risk than depression that occurred decades ago. This timing issue raises fundamental questions about causation. Is depression causing brain changes that eventually lead to dementia? Or is depression sometimes an early manifestation of dementia itself, a psychological symptom appearing before the cognitive symptoms become obvious? Research suggests the answer might be “both,” depending on when depression occurs and other individual factors.

Understanding this connection matters for millions of people. Depression affects roughly one in five adults at some point in their lives, making it one of the most common mental health conditions. Dementia currently affects around 50 million people worldwide, with numbers projected to triple by 2050 as populations age. If depression genuinely increases dementia risk, and if treating depression effectively can reduce that risk, we’re looking at a potentially modifiable factor that could prevent or delay countless cases of cognitive decline. But if the association reflects depression as an early symptom rather than a true risk factor, the implications for prevention look very different.

This article explores what research reveals about the depression-dementia connection, examining the evidence for increased risk, the biological mechanisms that might explain the link, the critical importance of timing, what this means for prevention and treatment, and how to think about your own or a loved one’s risk. Because while the science is complex, the human stakes are profound—understanding this relationship could inform decisions about mental health treatment, lifestyle modifications, and planning for cognitive health as we age.

The Evidence: What Research Shows About Risk

The scientific literature examining whether depression increases dementia risk has grown substantially over the past two decades, and the findings paint a consistent picture: yes, there is a significant association. But as with most questions in medicine and psychology, the devil lives in the details.

Multiple large-scale studies tracking thousands of people over many years have documented elevated dementia risk among those with depression histories. One particularly robust study followed a population-based cohort for 17 years, finding that depression was associated with nearly double the risk of developing dementia and Alzheimer’s disease after controlling for age, sex, education, genetics, and other factors. This wasn’t a small effect that barely reached statistical significance—it was a substantial increase in risk that persisted even after excluding people who might have already been experiencing early cognitive decline.

A massive Swedish cohort study examining over 1.3 million people investigated how both chronic stress and depression affect dementia risk. The findings were striking: depression alone increased risk, chronic stress alone increased risk, but the combination of both created an additive effect—people dealing with both documented stress and depression faced even higher likelihood of developing mild cognitive impairment or Alzheimer’s disease. This suggests that the mechanisms linking depression to dementia might be amplified when stress is also present, which makes sense given that many people experience depression in the context of chronic life stressors.

Research specifically examining older adults with both depression and mild cognitive impairment—that intermediate state between normal aging and dementia—found particularly high progression rates to Alzheimer’s. In one study following nearly 2,000 older adults with both conditions, many progressed to Alzheimer’s over relatively short follow-up periods. The presence of recently active depression (within the past two years) dramatically increased this risk compared to those with more remote depression histories. This suggests a gradient effect where more recent mood symptoms predict greater cognitive decline risk.

Importantly, research indicates that women may face higher risk than men. One study found that recent depression was significantly associated with increased Alzheimer’s risk in women but not men, with women experiencing depression within the past two years facing more than double the risk compared to those without recent depression. Given that women have roughly twice the lifetime risk of both depression and Alzheimer’s compared to men, understanding this sex-specific vulnerability could be crucial for targeted prevention efforts.

The research also reveals important nuances about depression characteristics that influence risk. Number of depressive episodes matters—people who’ve experienced multiple episodes show higher dementia risk than those with a single episode. Severity of symptoms plays a role, with more severe depression associated with greater cognitive decline risk. Age of onset shows complex patterns, with both early-life depression and late-life depression associated with increased risk, though potentially through different mechanisms.

However, not all research shows identical results. Some studies have found weaker associations or associations only in specific subgroups. The variability across studies likely reflects differences in how depression is measured (clinical diagnosis versus symptom questionnaires), how long people are followed (shorter versus longer), what types of dementia are examined (Alzheimer’s specifically versus all dementias), and how thoroughly researchers control for confounding variables. But the overall weight of evidence clearly supports a connection between depression and increased dementia risk.

Why Might Depression Increase Risk?

Establishing that depression and dementia are associated statistically is one thing—understanding why is another. Researchers have proposed several biological and psychological mechanisms that could explain how depression might contribute to cognitive decline and dementia development.

Chronic inflammation represents one of the most compelling potential mechanisms. Depression is associated with elevated inflammatory markers in the blood and brain—substances like C-reactive protein, interleukin-6, and tumor necrosis factor alpha. This isn’t just correlation; depression appears to trigger inflammatory processes, possibly through stress hormone pathways. Chronic inflammation, in turn, has been implicated in Alzheimer’s disease and other neurodegenerative conditions. Brain tissue from Alzheimer’s patients shows extensive inflammation, and inflammatory processes appear to contribute to the accumulation of abnormal proteins and neuronal damage characteristic of the disease. If depression maintains chronic low-grade inflammation over years or decades, this could gradually contribute to the brain changes underlying dementia.

Stress hormone dysregulation offers another pathway. Depression frequently involves abnormalities in the hypothalamic-pituitary-adrenal (HPA) axis—the system regulating cortisol and other stress hormones. Many people with depression show elevated cortisol levels, particularly chronic or treatment-resistant depression. High cortisol exposure over extended periods damages the hippocampus, a brain region critical for memory that shows early pathology in Alzheimer’s disease. Animal studies demonstrate that chronic stress and high cortisol can cause hippocampal atrophy and impair neurogenesis—the birth of new neurons. If depression maintains elevated stress hormones for years, this could accelerate hippocampal damage and increase vulnerability to dementia.

Vascular factors provide yet another connection. Depression increases risk for cardiovascular disease, stroke, and vascular problems that affect brain health. Some research suggests depression may promote atherosclerosis, endothelial dysfunction, and other vascular pathologies that reduce brain blood flow. Vascular dementia results directly from blood flow problems, while vascular disease also contributes to Alzheimer’s pathology. Depression’s effects on lifestyle—reduced physical activity, poor diet, smoking, medication non-adherence—further compound vascular risk. The cumulative impact of these factors over decades could significantly increase dementia likelihood.

Reduced neuroplasticity and brain-derived neurotrophic factor (BDNF) represents another proposed mechanism. BDNF is a protein essential for neuron survival, growth, and synaptic plasticity—the brain’s ability to form new connections and adapt. Depression is associated with reduced BDNF levels, and effective antidepressant treatment often increases BDNF. Lower BDNF could reduce the brain’s resilience and repair capacity, making it more vulnerable to age-related cognitive decline and pathological processes like amyloid accumulation. If depression suppresses these protective factors for years, cognitive reserve might be depleted, lowering the threshold for clinical dementia.

Behavioral and lifestyle factors associated with depression could indirectly increase risk. People experiencing depression often show reduced physical activity, poor sleep quality, social isolation, inadequate nutrition, and reduced engagement in cognitively stimulating activities—all factors independently associated with cognitive decline risk. Depression might not directly cause brain pathology but could increase risk by promoting behaviors that fail to protect or actively harm cognitive health. Additionally, depression is associated with higher rates of substance abuse, medication non-compliance, and reduced healthcare engagement, all of which could indirectly affect dementia risk.

Shared genetic or biological vulnerabilities might predispose some individuals to both depression and dementia. Certain genetic factors, early life adversity, or other constitutional vulnerabilities could increase susceptibility to both conditions without one necessarily causing the other. In this scenario, depression and dementia would show statistical association because they share common underlying causes rather than through direct causation.

Reality likely involves multiple mechanisms operating simultaneously or in sequence. Depression probably doesn’t cause dementia through a single pathway but rather through the accumulated impact of inflammation, stress hormones, vascular damage, reduced neuroplasticity, and adverse lifestyle factors acting over years or decades to gradually compromise brain health and cognitive reserve.

The Timing Question: Early Warning Sign or Risk Factor?

One of the most important and debated questions in this field concerns when depression occurs relative to dementia onset. This timing question fundamentally shapes how we interpret the association and what it means for prevention.

Research reveals a complex pattern where both early-life depression (occurring in young or middle adulthood) and late-life depression (emerging in older age) show associations with dementia risk, but they likely represent different scenarios with different implications.

Early-life depression—episodes occurring in someone’s 20s, 30s, 40s, or 50s—followed decades later by dementia more strongly suggests that depression might be a genuine risk factor. The long time interval between depression and dementia onset makes it less plausible that the depression was simply an early symptom of underlying dementia pathology. Studies examining this long-term relationship have found that people with depression in midlife face increased dementia risk decades later, and the risk increases with number of depressive episodes and symptom severity. This pattern suggests that depression during earlier life stages could trigger processes—inflammation, stress hormone effects, vascular damage, lifestyle changes—that accumulate over time and eventually contribute to dementia development.

Late-life depression emerging for the first time in someone’s 60s, 70s, or 80s presents a more ambiguous picture. On one hand, new-onset depression in older adults could represent a true risk factor, with the same mechanisms described above. On the other hand, late-life depression could sometimes be a prodromal symptom—an early manifestation of dementia processes already underway but not yet obvious through cognitive testing. Some older adults develop depression as amyloid plaques accumulate or as other brain changes associated with Alzheimer’s begin affecting mood-regulating circuits. In these cases, the depression doesn’t cause dementia; it’s an early part of the dementia process itself.

The research finding that recent depression (active within the past two years) shows much stronger association with dementia risk than remote depression supports this interpretation. If depression that occurred decades ago showed the strongest association, it would clearly suggest depression as a risk factor with long-term consequences. But the opposite pattern—where very recent depression shows the strongest association—suggests that at least some late-life depression represents prodromal dementia rather than a true risk factor.

However, the picture isn’t entirely either/or. Even when examining only recent depression, the association with dementia remains significant after excluding people who already showed cognitive impairment at baseline, suggesting the relationship isn’t entirely explained by depression being an early symptom. The truth likely involves both scenarios occurring in different individuals: some people’s late-life depression genuinely increases their dementia risk through biological mechanisms, while other people’s late-life depression reflects emerging dementia pathology.

Distinguishing between these scenarios in individual cases remains challenging. Certain features might help: depression emerging suddenly without clear precipitant in someone with no prior psychiatric history raises more suspicion for prodromal dementia than recurrent depression consistent with someone’s lifelong pattern. Depression accompanied by subtle cognitive changes, apathy, or neurological signs might more likely represent early dementia. But definitive distinction often requires long-term follow-up to see how symptoms evolve.

This ambiguity has important clinical implications. Should clinicians be more aggressive about treating late-life depression specifically to prevent dementia? Or is treating the underlying dementia pathology (if that’s what’s driving the depression) the more important goal? The answer probably involves treating depression vigorously regardless of its relationship to dementia risk, both because depression itself causes suffering and because even if it’s prodromal, effective treatment could still slow cognitive decline or improve quality of life.

What This Means for Prevention and Treatment

If depression genuinely increases dementia risk, the obvious question becomes: can treating depression effectively reduce that risk? This question has profound implications for dementia prevention strategies, yet research providing definitive answers remains surprisingly limited.

Observational studies examining whether antidepressant use reduces dementia risk have produced mixed results. Some studies suggest that treating depression might lower risk, while others find no protective effect or even increased risk associated with certain antidepressants. These conflicting findings likely reflect methodological challenges—people taking antidepressants by definition have depression, making it difficult to disentangle whether any observed effects come from the medication, from the depression itself, or from other factors. Randomized controlled trials—the gold standard for establishing causation—examining whether treating depression prevents dementia are limited and haven’t yet provided clear answers.

Despite this uncertainty, several compelling reasons support aggressively treating depression regardless of its effect on dementia risk. First, depression causes immense suffering in its own right—diminished quality of life, impaired functioning, physical health consequences, suicide risk. Treating depression is worthwhile purely for improving current wellbeing, independent of any future dementia prevention. Second, effective depression treatment might address some mechanisms linking depression to dementia—reducing inflammation, normalizing stress hormones, improving vascular health, increasing engagement in protective activities. Even if we lack definitive proof that treatment prevents dementia, addressing these pathways seems prudent. Third, depression impairs cognitive function itself, so treating it at minimum improves current cognitive performance even if long-term dementia risk remains unchanged.

Lifestyle interventions offer another prevention angle. Many factors that reduce depression risk also reduce dementia risk, suggesting common protective pathways. Regular physical activity powerfully combats both depression and cognitive decline. Social engagement protects against both conditions. Adequate sleep, healthy diet, stress management, and purposeful activity all support both mental health and cognitive health. Rather than viewing depression and dementia prevention as separate goals, an integrated approach targeting shared risk factors might prove most effective.

Emerging research on cognitive stimulation and mental health suggests that addressing both domains together might provide synergistic benefits. Some evidence indicates that older adults receiving combined interventions—depression treatment plus cognitive training, or group therapy that includes both emotional support and cognitively engaging activities—show better outcomes than either approach alone. This makes conceptual sense: depression impairs motivation and engagement with cognitive activities, while cognitive stimulation can improve mood and sense of mastery. Addressing both simultaneously might break negative cycles more effectively than treating either in isolation.

For individuals with both depression and mild cognitive impairment—the group at particularly high dementia risk—intensive intervention seems especially warranted. Research showing that older adults with this combination frequently progress to Alzheimer’s within a few years suggests that this population should be prioritized for aggressive treatment, close monitoring, and potentially enrollment in clinical trials of preventive interventions. The window for prevention might be narrow once cognitive impairment emerges, making early identification and intervention critical.

Psychotherapy, particularly cognitive-behavioral therapy, offers benefits beyond symptom reduction. CBT teaches skills for managing stress, challenging negative thinking, increasing behavioral activation, and improving problem-solving—all potentially beneficial for cognitive health and resilience. The cognitive aspects of CBT—identifying patterns, organizing information, planning behaviors—themselves provide cognitive exercise. Some research suggests that psychotherapy might be particularly beneficial for late-life depression given older adults’ higher rates of medical comorbidities and medication interactions that can complicate pharmacological treatment.

Public health approaches to depression prevention and early intervention could constitute dementia prevention strategies if the causal relationship is real. Programs reducing childhood adversity, promoting resilience, ensuring access to mental health treatment, and reducing depression’s duration through early identification could theoretically reduce cumulative lifetime depression exposure and thereby lower dementia risk decades later. While proving such long-term effects requires decades of follow-up and may never be definitively established, the potential justifies investment in mental health care as part of comprehensive brain health initiatives.

Assessing and Managing Your Own Risk

If you’ve experienced depression, particularly multiple episodes or chronic symptoms, learning about its association with dementia can understandably trigger anxiety. How should you think about your own risk, and what practical steps make sense?

First, remember that risk is probabilistic, not deterministic. Having depression increases dementia risk but doesn’t guarantee you’ll develop it—most people with depression histories won’t develop dementia. Think of it like smoking and lung cancer: smoking substantially increases risk, but most smokers don’t get lung cancer, and not getting lung cancer doesn’t validate smoking. The increased risk is real and meaningful at population level while remaining uncertain for any individual.

Second, contextualize the risk within your broader health picture. Dementia risk depends on numerous factors: age, genetics (particularly the APOE ε4 gene), cardiovascular health, education level, physical activity, social engagement, hearing health, head injury history, and many others. Depression represents just one piece of a complex puzzle. If you have depression but maintain other protective factors—regular exercise, strong social connections, good cardiovascular health, cognitive engagement—your overall risk profile looks different than someone with depression plus multiple other risk factors.

Third, focus on factors within your control. You can’t change your depression history or genetic predisposition, but you can influence many other risk factors. Ensure depression treatment is optimized—working with mental health professionals to find effective interventions, whether medication, therapy, or both. Address cardiovascular risk factors like hypertension, diabetes, and high cholesterol through regular medical care. Maintain physical activity—even moderate exercise shows substantial benefits for both mood and cognitive health. Cultivate social connections and engage in activities that provide meaning and purpose. Protect your hearing and treat hearing loss, which emerges as an important modifiable dementia risk factor. Challenge your brain through learning, reading, puzzles, or other cognitively stimulating activities.

Fourth, if you’re older and experiencing new or worsening mood symptoms alongside memory concerns, discuss both with your healthcare provider. The combination warrants thorough evaluation, including cognitive testing, depression assessment, and consideration of whether mood symptoms might reflect emerging cognitive impairment. Early identification of mild cognitive impairment allows for closer monitoring, potential participation in clinical trials, and proactive management of other risk factors.

Fifth, don’t let anxiety about future dementia risk undermine your current mental health. Worrying excessively about whether depression will cause dementia decades from now isn’t helpful and itself impairs present wellbeing. Focus on managing current depression effectively, both because it improves your life now and because it likely represents your best strategy for reducing any increased dementia risk. Ruminating about future possibilities you can’t control is itself a depressive thinking pattern worth addressing in therapy.

Finally, maintain perspective about what we know and don’t know. The research clearly establishes association between depression and dementia, but our understanding of mechanisms, which subgroups face highest risk, whether certain treatments reduce risk, and how to optimize prevention remains incomplete. Science continues evolving, and recommendations may change as evidence accumulates. Stay informed, but don’t over-interpret preliminary findings or make drastic life changes based on studies that may later be qualified or contradicted.

FAQs About Depression and Dementia Risk

If I had depression 20 years ago but I’m fine now, am I still at higher risk?

Research suggests that remote depression—meaning episodes that occurred many years ago—shows much weaker association with dementia risk compared to recent depression. Some studies find that depression active more than two years ago doesn’t significantly increase risk after accounting for other factors, while others show modest elevation. The pattern generally indicates that more recent depression carries higher risk, though some research examining depression in midlife followed for decades does find increased risk. Your overall risk likely depends on multiple factors beyond that historical depression: how many episodes you experienced, how severe they were, whether you developed effective coping strategies, and your current health status across multiple domains. Having experienced depression decades ago without recurrence probably doesn’t dramatically elevate your risk compared to someone who never had depression, particularly if you’ve maintained good physical and mental health in the interim. The bigger concern would be if depression recurs or if you develop other risk factors. Focus on maintaining current mental health, addressing modifiable dementia risk factors like cardiovascular health and physical activity, and staying engaged with life rather than worrying excessively about historical depression.

Can treating my current depression actually prevent dementia, or is the damage already done?

This question doesn’t have a definitive answer yet because research hasn’t conclusively established whether effective depression treatment reduces future dementia risk. However, several reasons support treating depression optimally regardless. First, depression impairs current cognitive function, so treatment at minimum improves present mental clarity and memory even if it doesn’t affect long-term risk. Second, treating depression likely addresses some proposed mechanisms linking it to dementia—reducing inflammation, normalizing stress hormones, increasing activity levels, improving sleep—all of which could plausibly reduce risk even if we can’t yet prove it. Third, depression increases risk for cardiovascular disease and stroke, which themselves increase dementia risk, so treating depression and its associated lifestyle factors could reduce risk through vascular pathways. Fourth, effective treatment improves engagement with protective activities like exercise, social connection, and cognitive stimulation. The concept of “damage already done” probably doesn’t apply—the brain retains plasticity and resilience throughout life. Even if past depression created some vulnerabilities, treating current depression and optimizing other risk factors almost certainly helps more than resigning yourself to inevitable decline. The prudent approach is treating depression vigorously with evidence-based interventions while also addressing lifestyle factors that protect cognitive health.

How can I tell if my memory problems are from depression or early dementia?

Distinguishing between cognitive impairment from depression (often called pseudodementia) and actual emerging dementia can be challenging because the symptoms overlap significantly. Some general patterns can help, though definitive diagnosis often requires professional evaluation over time. Depression-related cognitive problems typically include subjective distress about memory—people with depression worry intensely about their memory and often overestimate their impairment. In contrast, people with early dementia frequently minimize their deficits or seem unaware of them. Depression-related cognitive symptoms often fluctuate with mood—worse during depressive episodes, better when mood improves. Dementia symptoms generally progress steadily regardless of mood. Memory testing in depression-related cognitive problems typically shows inconsistent performance with better results when the person makes effort, while dementia shows consistently impaired performance. Depression typically affects concentration, processing speed, and effort-dependent tasks more than learning new information or recognizing previously learned material, whereas dementia impairs formation of new memories and recognition. However, these distinctions aren’t absolute, and some people have both depression and emerging dementia. The most reliable approach involves comprehensive evaluation by specialists—neuropsychological testing that carefully assesses different cognitive domains, monitoring symptoms over time to see if they improve with depression treatment or progress despite it, and sometimes neuroimaging to look for structural brain changes. If you’re concerned about your memory, discuss with your healthcare provider who can refer you for appropriate evaluation.

Are some types of depression more likely to lead to dementia than others?

Research examining whether specific depression subtypes carry different dementia risks remains limited, but some patterns have emerged. Depression characterized by severe symptoms, multiple episodes, longer duration, and treatment resistance appears associated with higher risk than single, mild, or brief episodes. This makes sense—more severe and chronic depression likely creates more cumulative biological impact through inflammation, stress hormones, and other mechanisms. Depression with prominent psychomotor retardation (slowed movement and thinking) might carry particular risk, possibly because it shares features with subcortical dementias. Some research suggests depression accompanied by high anxiety might increase risk more than depression alone, possibly reflecting chronic stress effects. Late-onset depression emerging for the first time in older adulthood sometimes indicates higher risk, though this might reflect prodromal dementia rather than depression causing risk. Vascular depression—depression associated with cerebrovascular disease, often presenting with apathy, psychomotor retardation, and executive dysfunction—shows strong association with both vascular dementia and Alzheimer’s disease, likely because the underlying vascular pathology contributes to both conditions. Postpartum depression or depression clearly related to specific life circumstances probably carries less long-term risk than endogenous depression without clear external triggers, though research specifically addressing this is limited. The overall message is that more severe, chronic, or biologically-driven depression likely poses greater risk than milder or reactive forms, but any significant depression warrants treatment.

Should older adults with both depression and memory problems be treated differently?

Yes, older adults presenting with both depressive symptoms and cognitive concerns warrant particularly careful evaluation and potentially more intensive intervention. This combination represents a high-risk scenario—research shows that people with both depression and mild cognitive impairment face dramatically elevated rates of progression to Alzheimer’s disease, particularly if depression is recently active. Evaluation should include thorough cognitive testing to characterize the nature and severity of impairment, comprehensive depression assessment to determine symptom severity and treatment needs, medical workup to identify treatable causes (thyroid disease, B12 deficiency, medication effects), and often neuroimaging to assess for vascular disease or other structural changes. Treatment typically involves aggressive depression management using evidence-based approaches—medication, psychotherapy, or combination treatment—with close monitoring of response. Cognitive symptoms should be reassessed after depression treatment to determine if they improve (suggesting depression-related pseudodementia) or persist (suggesting underlying dementia). Even when cognitive impairment persists, treating depression often improves function and quality of life. This population should be considered for clinical trials of interventions aimed at preventing dementia progression. Family involvement in treatment planning is often important given potential cognitive impairments affecting decision-making. Regular follow-up to monitor both mood and cognition allows early detection of progression and adjustment of treatment plans. The combination of depression and cognitive impairment shouldn’t be dismissed as normal aging—it represents a red flag warranting comprehensive evaluation and proactive management.

Does having a family history of both depression and dementia mean I’m doomed?

Having family history of both conditions understandably raises concerns, but it definitely doesn’t mean you’re “doomed”—genetic predisposition isn’t destiny. First, understand that both depression and dementia have complex inheritance patterns involving multiple genes plus environmental factors. Having relatives with these conditions increases your risk compared to someone without such family history, but most genetic risk comes from many genes each contributing small effects rather than single determinant genes. The APOE ε4 gene variant increases Alzheimer’s risk substantially, but even two copies don’t guarantee you’ll develop it, and testing for this variant is controversial given limited ability to act on the information. Some genetic factors might predispose to both depression and dementia, but we don’t yet understand these shared genetic vulnerabilities well enough to make specific predictions. More importantly, numerous modifiable factors influence whether genetic risk manifests. Physical activity, cognitive engagement, social connection, cardiovascular health management, education, and other lifestyle factors substantially affect dementia risk even in people with genetic vulnerabilities. Similarly, building resilience, developing healthy coping strategies, addressing stress, and seeking early treatment for mood symptoms can reduce depression risk and severity even with family history. View family history as information about your risk profile that motivates proactive health management rather than a prediction of inevitable outcome. Use it as motivation to optimize controllable factors—maintain physical activity, nurture social connections, manage cardiovascular risk factors, treat depression promptly and effectively, stay cognitively engaged, and cultivate resilience. Many people with significant family histories of these conditions never develop them, while others without family history do. Focus your energy on factors within your control rather than worrying about inherited risk you can’t change.